Solesence, Inc. (SLSN)

What does Solesence actually make?

Solesence, which rebranded from Nanophase Technologies in March 2025, is not a household-name cosmetics company like Estée Lauder or L’Oréal. It is not a pure ingredient supplier like specialty chemical firms. Instead, it occupies a middle ground: it engineers the raw mineral particles that go into sunscreen and skincare products, then formulates and sells finished skincare products containing those engineered particles to direct consumers and through distribution partners.

The core minerals are zinc oxide and titanium dioxide — the two inorganic UV filters approved by the FDA as active pharmaceutical ingredients for sunscreen. Solesence has spent decades developing processes to coat, disperse, and size these minerals at the nanoscale to achieve specific optical and cosmetic properties. One of its proprietary products is called Kleair — a high-transparency zinc oxide that allegedly eliminates the “ghosting” (white streaks and cast) that plagues many mineral sunscreens, making them less attractive to consumers who prefer invisible coverage.

Why does particle engineering matter?

The economics of cosmetics often hinge on small details. A sunscreen that leaves a white cast on skin looks poor; consumers avoid it. A sunscreen that is invisible but provides broad-spectrum protection and stays put through water and sweat is premium. Solesence’s value proposition is that its engineered particles, by virtue of their size, surface coatings, and dispersion behavior, allow formulators to create mineral sunscreens that deliver both efficacy and aesthetics. That advantage is defensible because it requires proprietary know-how and capital investment in manufacturing capability.

Solesence has licensed its engineered particles to major cosmetics brands for use in their sunscreen and skincare lines. These are business-to-business relationships; the particles are sold to formulators who then use them in products sold under their own brands. But Solesence has also launched its own direct-to-consumer skincare brand, Solesence Beauty Science, selling finished sunscreens and daily skincare products containing its proprietary mineral technology.

The parent company’s broader business

Solesence Inc (the parent) operates beyond beauty. Its engineered zinc oxide and titanium dioxide particles are also sold to manufacturers of coatings, plastics, diagnostics, and industrial applications. The company supplies medical diagnostic companies, architectural coatings manufacturers, and industrial users who need specialty mineral powders. This diversification cushions against cycles in any one market, though it also means the company must compete across many distinct customer bases with different technical demands and pricing sensitivity.

Timing and scale

For decades, mineral sunscreens were a niche product — associated with dermatology, sensitive skin, and premium pricing. In recent years, three trends have converged to expand the market. First, consumer concern about synthetic UV filters (particularly oxybenzone and avobenzone) and potential endocrine-disrupting effects has driven migration toward mineral sunscreens as a perceived safer alternative. Second, clean beauty and the broader move toward “natural” or “green” cosmetics has positioned mineral over synthetic. Third, social media has amplified skincare routines and sun protection consciousness, driving higher unit volumes in sunscreen than ever before.

These are precisely the conditions that favor a company like Solesence. It is large enough to have manufacturing scale and proprietary technology, yet small enough to be nimble in product development and to move quickly into emerging subsegments (like tinted mineral sunscreens, or sunscreen-skincare hybrids). In 2024, Solesence reported full-year revenue of $52.3 million, a 40 percent increase year-over-year, and net income of $4.2 million, demonstrating profitability in a market still growing.

Scale asymmetries

Solesence is not competing with Estée Lauder or LVMH — companies with dozens of brands, billions in revenue, and distribution in every major market. Instead, it is competing with specialized ingredient suppliers and with smaller skincare brands that formulate and sell mineral sunscreens directly. Its advantage is vertical integration: it owns the particle science, manufactures the particles, formulates products, and sells under its own brand. A pure ingredient supplier like that has less control over the end product and brand reputation. A pure skincare brand without particle expertise must license technology from suppliers like Solesence.

Being small also carries drawbacks. Solesence does not have the scale to spend $100 million on a global brand campaign; it relies on social media, word of mouth, and distribution partnerships. It does not have the purchasing power of a megacap cosmetics company, so ingredient costs may be proportionally higher. And it lacks the diversity of the largest cosmetics conglomerates: if mineral sunscreen demand cools, or if a competitor develops superior technology, Solesence has fewer hedges.

What to watch

Readers studying Solesence should examine the company’s SEC filings (CIK 0000883107) for revenue by segment — particularly the mix of ingredient sales to third-party formulators versus direct-to-consumer skincare revenue. The company’s gross margins, especially for the Solesence Beauty Science line, reveal the economics of direct sales versus business-to-business ingredient supply. The company’s recent patent portfolio also indicates the direction of innovation: new coatings, new size distributions, new formulation approaches.

Competitive dynamics matter. The mineral sunscreen market has attracted new entrants and investments from larger beauty companies. If a major player launches a breakaway product that captures significant market share, or if ingredient costs rise due to supply shocks, Solesence’s growth could stall. Conversely, if the clean-beauty trend accelerates and consumers become more willing to pay premiums for mineral-based products with superior cosmetics, Solesence could sustain high growth and expanding margins. The company’s success depends on sustaining its technical edge in particle engineering and converting consumer demand for mineral sunscreen into profitable volume.